Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/12/2002 | US20020187520 Allergen/ inflammatory testing and diagnosis |
12/12/2002 | US20020187498 Screening modulators of skin allergies; obtain sample, incubate with modulator, monitor and evaluate response |
12/12/2002 | US20020187492 Nucleotide sequences coding polypeptides for use in the treatnment of inflammation |
12/12/2002 | US20020187472 Nucleotide sequences coding protein for use in the treatment of cancer |
12/12/2002 | US20020187157 Administering an amyloidogenic polypeptide or subsequence thereof to induces production of antibodies against the amyloidogenic polypeptide; treatment of Alzheimer's disease |
12/12/2002 | US20020187140 Two novel human cathepsin proteins |
12/12/2002 | US20020187135 Methods for inducing antigen-specific t cell tolerance |
12/12/2002 | US20020187133 Methods of isolating bipotent hepatic progenitor cells |
12/12/2002 | US20020187128 Novel replication deficient adenovirus vectors and methods for making and using them |
12/12/2002 | CA2463310A1 Compositions and methods for high-level, large-scale production of recombinant proteins |
12/12/2002 | CA2452865A1 Conditioned cell culture media and uses thereof |
12/12/2002 | CA2449885A1 Improved isoprenoid production |
12/12/2002 | CA2449783A1 Microfabricated tissue as a substrate for pigment epithelium transplantation |
12/12/2002 | CA2449670A1 Mutant forms of cholera holotoxin as an adjuvant |
12/12/2002 | CA2449663A1 Mutant forms of cholera holotoxin as an adjuvant |
12/12/2002 | CA2449487A1 Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity |
12/12/2002 | CA2449482A1 Chds as modifiers of the p53 pathway and methods of use |
12/12/2002 | CA2449479A1 Map3ks as modifiers of the p53 pathway and methods of use |
12/12/2002 | CA2449466A1 Peripheral blood fibrocytes differentiation pathway and migration to wound sites |
12/12/2002 | CA2449425A1 Slc2as as modifiers of the p53 pathway and methods of use |
12/12/2002 | CA2449303A1 Method for targeting transcriptionally active loci |
12/12/2002 | CA2449289A1 Gfats as modifiers of the p53 pathway and methods of use |
12/12/2002 | CA2449281A1 Prmts as modifiers of the p53 pathway and methods of use |
12/12/2002 | CA2449275A1 Dgks as modifiers of the p53 pathway and methods of use |
12/12/2002 | CA2449270A1 Pibs as modifiers of the p53 pathway and methods of use |
12/12/2002 | CA2449267A1 Hs2sts as modifiers of the p53 pathway and methods of use |
12/12/2002 | CA2449206A1 Cads as modifiers of the p53 pathway and methods of use |
12/12/2002 | CA2449136A1 Igs as modifiers of the p53 pathway and methods of use |
12/12/2002 | CA2448824A1 Novel compounds for chemiluminescense procedures |
12/12/2002 | CA2448606A1 Nucleic acid-associated proteins |
12/12/2002 | CA2448591A1 T cell induced tissue repair and regeneration |
12/12/2002 | CA2448444A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
12/12/2002 | CA2448427A1 Molecules and methods for inhibiting shedding of kim-1 |
12/12/2002 | CA2448384A1 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent |
12/12/2002 | CA2448282A1 Slc7s as modifiers of the p53 pathway and methods of use |
12/12/2002 | CA2448250A1 Limks as modifiers of the p53 pathway and methods of use |
12/12/2002 | CA2448112A1 Lces as modifiers of the p53 pathway and methods of use |
12/12/2002 | CA2448107A1 Marks as modifiers of the p53 pathway and methods of use |
12/12/2002 | CA2448066A1 Chimeric alphavirus replicon particles |
12/12/2002 | CA2447935A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
12/12/2002 | CA2446211A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
12/12/2002 | CA2430697A1 Atp-binding cassette transporter-like molecules and uses thereof |
12/12/2002 | CA2418088A1 Numb protein expression inhibitors by musashi 1 |
12/11/2002 | EP1264891A1 Modification of plant genomes by inducible site-specific recombination of transgenes |
12/11/2002 | EP1264889A1 Chicken leukemia inhibitory factor (LIF) and the gene thereof |
12/11/2002 | EP1264888A2 A modified fluorescent protein |
12/11/2002 | EP1264886A1 Improved promoters and utilization thereof |
12/11/2002 | EP1264880A1 Double-transfected cell line useful for the identification of transport inhibitors |
12/11/2002 | EP1264879A1 Isolation of a cluster of cells from an isolated organ using magnetic particle |
12/11/2002 | EP1264878A2 Method of providing a substrate with a ready-to-use, uniformly distributed extracellular matrix |
12/11/2002 | EP1264877A1 Cell cultivation-support material, method of cocultivation of cells and cocultivated cell sheet obtained therefrom |
12/11/2002 | EP1264842A1 Novel proteins and novel genes encoding the same |
12/11/2002 | EP1263982A1 Phosphatidyl serine receptors and uses thereof |
12/11/2002 | EP1263977A2 Methods and compositions to reduce or eliminate transmission of a transgene |
12/11/2002 | EP1263972A2 Methods for homologous recombination |
12/11/2002 | EP1263970A1 Identification of a dual specificity phosphatase: dusp-10 |
12/11/2002 | EP1263968A1 Beta 1, 2-xylosyltransferase-gene from arabidopsis |
12/11/2002 | EP1263964A2 Recombinant hhv8 dna |
12/11/2002 | EP1263963A2 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
12/11/2002 | EP1263960A2 Anti-tissue factor antibodies with enhanced anticoagulant potency |
12/11/2002 | EP1263958A2 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
12/11/2002 | EP1263957A2 Human lipid binding protein 1 |
12/11/2002 | EP1263956A2 Human genes and gene expression products |
12/11/2002 | EP1263955A2 Polypeptides and nucleic acids encoding same |
12/11/2002 | EP1263954A2 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
12/11/2002 | EP1263948A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/11/2002 | EP1263946A2 New qtl's on chromosomes x, 2, 6 and 7 of pigs |
12/11/2002 | EP1263944A2 Nucleic acids, proteins, and antibodies |
12/11/2002 | EP1263943A1 Protein c derivatives |
12/11/2002 | EP1263940A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
12/11/2002 | EP1263938A1 Udp-galactose: beta-d-galactose-r 4-alpha-d-galactosyltransferase, alpha4gal-t1 |
12/11/2002 | EP1263937A2 Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use |
12/11/2002 | EP1263936A1 Altered strain of the modified vaccinia virus ankara (mva) |
12/11/2002 | EP1263933A2 Treatment for bone disorders |
12/11/2002 | EP1263932A1 Embryonic stem cells and neural progenitor cells derived therefrom |
12/11/2002 | EP1263931A2 Augmentation and repair of age-related soft tissue defects |
12/11/2002 | EP1263930A1 Human cord blood as a source of neural tissue for repair of the brain and spinal cord |
12/11/2002 | EP1263929A2 Artificial bone chips, methods for the production thereof and their use |
12/11/2002 | EP1263928A1 Cytotoxic t lymphocytes activated by dendritic cell hybrids |
12/11/2002 | EP1263791A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
12/11/2002 | EP1263790A1 Monoclonal antibodies to the human ldl receptor, their production and use |
12/11/2002 | EP1263787A2 G-protein coupled receptors |
12/11/2002 | EP1263784A1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
12/11/2002 | EP1263782A2 Leafy cotyledon2 genes and their uses |
12/11/2002 | EP1263780A2 Liv-1 related protein, polynulceotides encoding the same and use thereof for treatment of cancer |
12/11/2002 | EP1263771A2 Chemoselective ligation by use of a phosphine |
12/11/2002 | EP1263769A1 Dna molecules encoding a glutamate-gated chloride channel in drosophila melanogaster |
12/11/2002 | EP1263768A2 Chimeric neuropeptide y receptors |
12/11/2002 | EP1263767A2 Beta netrin and uses thereof |
12/11/2002 | EP1263766A1 Adam polynucleotides, polypeptides, and antibodies |
12/11/2002 | EP1263765A1 ALTERATION OF CELLULAR BEHAVIOR BY ANTISENSE MODULATION OF mRNA PROCESSING |
12/11/2002 | EP1263521A2 A method of sorting cells |
12/11/2002 | EP1263484A1 Coating which promotes endothelial cell adherence |
12/11/2002 | EP1263452A2 Methods and compositions for generating angiostatin |
12/11/2002 | EP1263450A1 Method and apparatus for inducing a cellular response |
12/11/2002 | EP1263449A1 Induction of beta cell differentiation in human cells by stimulation of the glp-1 receptor |
12/11/2002 | EP1263279A1 Method for producing somatic embryos of scots pine (p. sylvestris) |
12/11/2002 | EP0971728B1 Use of interleukin-15 |
12/11/2002 | EP0956009B9 Treatment of neurodegenerative conditions with nimesulide |
12/11/2002 | EP0888384B1 Fusion polypeptide for modifying interactions between proteins |